Companies: 10,795·Total market cap: $144.5T
NeoGenomics, Inc.

NeoGenomics, Inc.

NEONASDAQHealthcare● Active
$10.95
+$0.05(+0.46%)
Market Cap$285163798
P/E Ratio
52W High$13.74
52W Low$4.72
Overview

NeoGenomics, Inc.(NEO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · NEO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.73B$0.66B$0.59B$0.51B$0.48B
Cost of Revenue$0.44B$0.37B$0.35B$0.32B$0.30B
Gross Profit$0.28B$0.29B$0.24B$0.19B$0.19B
Gross Margin %(computed)38.85%43.92%41.34%36.86%38.62%
Operating Expenses
R&D Expenses$0.04B$0.03B$0.03B$0.03B$0.02B
G&A Expenses$0.27B$0.23B$0.21B$0.21B$0.22B
Total Operating Expenses$0.35B$0.38B$0.35B$0.35B$0.31B
Operating Income($0.07B)($0.09B)($0.11B)($0.16B)($0.12B)
Operating Margin %(computed)-9.09%-13.94%-18.21%-30.92%-24.52%
Interest Income$0.01B$0.02B$0.02B$0.01B$0.00B
Interest Expense$0.00B$0.01B$0.01B$0.01B$0.01B
Income Before Tax($0.11B)($0.08B)($0.10B)($0.16B)($0.02B)
Income Tax Expense($0.00B)($0.00B)($0.01B)($0.02B)($0.01B)
Net Income($0.11B)($0.08B)($0.09B)($0.14B)($0.01B)
Net Margin %(computed)-14.85%-11.92%-14.87%-28.30%-1.72%
Per Share & EBITDA
EPS (Basic)$-4.20$-3.10$-3.50$-5.80$-0.35
Wtd Avg Shares0.03B0.03B0.03B0.02B0.02B
EBITDA$0.00B($0.00B)($0.02B)($0.08B)($0.07B)
EBITDA Margin %(computed)0.24%-0.23%-2.98%-16.15%-13.50%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解NeoGenomics, Inc.

关于NeoGenomics, Inc.(NEO)损益表

NeoGenomics, Inc.(NEO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,NEO实现营收$0.73B,毛利润$0.28B(毛利率38.85%),净利润($0.11B)(净利率-14.85%)。

常见问题

NEO · 4 问

NeoGenomics, Inc.(NEO)2025财年营收为$0.73B,同比up10.1%。

NEO revenueNEO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09